KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CMRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Chimerix stock price ended at $0.89 on Thursday, after losing 1.66%.
(Updated on Apr 25, 2024)

Sell candidate since Apr 10, 2024 Loss -10.81% PDF

The Chimerix stock price fell by -1.66% on the last day (Thursday, 25th Apr 2024) from $0.91 to $0.89. During the last trading day the stock fluctuated 6.63% from a day low at $0.88 to a day high of $0.94. The price has fallen in 6 of the last 10 days and is down by -10% for this period. Volume has increased on the last day by 159 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 242 thousand shares were bought and sold for approximately $215.59 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.88 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -6.29% during the next 3 months and, with a 90% probability hold a price between $0.82 and $1.14 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CMRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 0.746%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Chimerix stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.91 and $1.02. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Chimerix gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Chimerix stock

Chimerix finds support from accumulated volume at $0.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0584 between high and low, or 6.63%. For the last week, the stock has had daily average volatility of 5.43%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CMRX) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Chimerix to open at $0.90, and during the day (based on 14 day Average True Range), to move between $0.84 and $0.95, which gives a possible trading interval of +/-$0.0551 (+/-6.18%) up or down from last closing price. If Chimerix takes out the full calculated possible swing range there will be an estimated 12.36% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.88 (0.74%) than the resistance at $0.96 (7.74%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Chimerix will release earnings BMO on Wednesday, May 01, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.210. We will update the financials statements for Chimerix, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 12.16% in the first trading day after earnings release.

Is Chimerix stock A Buy?

Chimerix holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.505 Sell Candidate Unchanged

Predicted Opening Price for Chimerix of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$0.90 ( 1.47%) $0.89

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CMRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.96 8.03 %
R2 0.94 5.52 %
R1 0.93 3.98 %
Current price: 0.89
Support S1 0.88 -1.03 %
S2 0.87 -2.58 %
S3 0.85 -5.08 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.05 17.85 %
R2 1.04 16.72 %
R1 0.96 7.74 %
Current price 0.89
Support S1 0.88 -0.741%
S2 0 .
S3 0 .

FAQ

What is the symbol for Chimerix Stock and on which exchange is it traded?
The symbol for Chimerix is CMRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Chimerix Stock?
Chimerix holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Chimerix Stock?
Chimerix Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Chimerix Stock.

What's the current price of Chimerix Stock?
As of the end of day on the Apr 25, 2024, the price of an Chimerix (CMRX) share was $0.89.

What is the 52-week high and low for Chimerix Stock?
The 52-week high for Chimerix Stock is $1.57 and the 52-week low is $0.88.

What is the market capitalization of Chimerix Stock?
As of the Apr 25, 2024, the market capitalization of Chimerix is 79.486M.

When is the next earnings date for Chimerix?
The upcoming earnings date for Chimerix is May 01, 2024.
Click to get the best stock tips daily for free!

About Chimerix

Chimerix Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midl... CMRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT